43 related articles for article (PubMed ID: 9923816)
1. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
[TBL] [Abstract][Full Text] [Related]
2. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates.
Anselmi M; Borbély A; Figueras E; Michalek C; Kemker I; Gentilucci L; Sewald N
Chemistry; 2021 Jan; 27(3):1015-1022. PubMed ID: 32955139
[TBL] [Abstract][Full Text] [Related]
3. Conjugates of Cryptophycin and RGD or
Borbély A; Figueras E; Martins A; Bodero L; Raposo Moreira Dias A; López Rivas P; Pina A; Arosio D; Gallinari P; Frese M; Steinkühler C; Gennari C; Piarulli U; Sewald N
ChemistryOpen; 2019 Jun; 8(6):737-742. PubMed ID: 31275795
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis and biological evaluation of fluorinated cryptophycins.
Weiß C; Bogner T; Sammet B; Sewald N
Beilstein J Org Chem; 2012; 8():2060-6. PubMed ID: 23209540
[TBL] [Abstract][Full Text] [Related]
5. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
[TBL] [Abstract][Full Text] [Related]
6. Bioactive Peptides Produced by Cyanobacteria of the Genus
Fidor A; Konkel R; Mazur-Marzec H
Mar Drugs; 2019 Sep; 17(10):. PubMed ID: 31569531
[TBL] [Abstract][Full Text] [Related]
7. New Drugs from the Sea: Pro-Apoptotic Activity of Sponges and Algae Derived Compounds.
Ercolano G; De Cicco P; Ianaro A
Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30621025
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric Syntheses of Potent Antitumor Macrolides Cryptophycin B and Arenastatin A.
Ghosh AK; Bischoff A
European J Org Chem; 2004 May; 2004(10):2131-2141. PubMed ID: 30443158
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Both Enantiomers of Chiral Phenylalanine Derivatives Catalyzed by Cinchona Alkaloid Quaternary Ammonium Salts as Asymmetric Phase Transfer Catalysts.
Jin L; Zhao S; Chen X
Molecules; 2018 Jun; 23(6):. PubMed ID: 29895754
[TBL] [Abstract][Full Text] [Related]
10. Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?
Fanale D; Bronte G; Passiglia F; Calò V; Castiglia M; Di Piazza F; Barraco N; Cangemi A; Catarella MT; Insalaco L; Listì A; Maragliano R; Massihnia D; Perez A; Toia F; Cicero G; Bazan V
Anal Cell Pathol (Amst); 2015; 2015():690916. PubMed ID: 26484003
[TBL] [Abstract][Full Text] [Related]
11. Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.
Costa M; Costa-Rodrigues J; Fernandes MH; Barros P; Vasconcelos V; Martins R
Mar Drugs; 2012 Oct; 10(10):2181-2207. PubMed ID: 23170077
[TBL] [Abstract][Full Text] [Related]
12. Efficient, divergent synthesis of cryptophycin unit A analogues.
Bolduc KL; Larsen SD; Sherman DH
Chem Commun (Camb); 2012 May; ():. PubMed ID: 22617820
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic optimization of 4-substituted methoxybenzoyl-aryl-thiazole and 2-aryl-4-benzoyl-imidazole for improving oral bioavailability.
Li CM; Chen J; Lu Y; Narayanan R; Parke DN; Li W; Ahn S; Miller DD; Dalton JT
Drug Metab Dispos; 2011 Oct; 39(10):1833-9. PubMed ID: 21742898
[TBL] [Abstract][Full Text] [Related]
14. Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.
Chlipala GE; Mo S; Orjala J
Curr Drug Targets; 2011 Oct; 12(11):1654-73. PubMed ID: 21561419
[TBL] [Abstract][Full Text] [Related]
15. Microtubule-binding agents: a dynamic field of cancer therapeutics.
Dumontet C; Jordan MA
Nat Rev Drug Discov; 2010 Oct; 9(10):790-803. PubMed ID: 20885410
[TBL] [Abstract][Full Text] [Related]
16. Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp.
Chlipala GE; Sturdy M; Krunic A; Lantvit DD; Shen Q; Porter K; Swanson SM; Orjala J
J Nat Prod; 2010 Sep; 73(9):1529-37. PubMed ID: 20825206
[TBL] [Abstract][Full Text] [Related]
17. Drug development from marine natural products.
Molinski TF; Dalisay DS; Lievens SL; Saludes JP
Nat Rev Drug Discov; 2009 Jan; 8(1):69-85. PubMed ID: 19096380
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
Ding Y; Seufert WH; Beck ZQ; Sherman DH
J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
[TBL] [Abstract][Full Text] [Related]
19. Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells.
Kamau SW; Krämer SD; Günthert M; Wunderli-Allenspach H
In Vitro Cell Dev Biol Anim; 2005; 41(7):207-16. PubMed ID: 16223335
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and toxicology of pahayokolide A, a bioactive metabolite from a freshwater species of Lyngbya isolated from the Florida Everglades.
Berry JP; Gantar M; Gawley RE; Wang M; Rein KS
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Dec; 139(4):231-8. PubMed ID: 15683832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
